Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth

[ad_1] Medical personnel use a mammogram to examine a woman’s breast for breast cancer. Hannibal Hanschke | dpa | Picture Alliance | Getty Images SAN FRANCISCO — An established but…

J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion

[ad_1] An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. Mark Ralston | AFP | Getty Images Johnson & Johnson…

Moderna stock pops after Oppenheimer says Covid shot maker could launch more products over next two years

[ad_1] Artur Widak | Nurphoto | Getty Images Shares of Moderna closed more than 13% higher on Tuesday after Oppenheimer upgraded the stock to “outperform,” saying the Covid vaccine maker…

Biden administration’s Medicare drug price negotiations will face major tests in 2024

[ad_1] Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) building on October 06, 2022 in Washington, DC. Anna…

Moderna, Merck vaccine with Keytruda cuts risk of deadly skin cancer returning in half, data says

[ad_1] An exterior view of Moderna’s clinical manufacturing facility.  David L. Ryan | Boston Globe | Getty Images Moderna and Merck‘s experimental cancer vaccine, when used in combination with Merck’s…

Pfizer shares fall as 2024 revenue and profit forecast disappoints

[ad_1] Shares of Pfizer fell Wednesday after the drugmaker forecast 2024 revenue and profit below Wall Street’s expectations, as it sees weak demand for its once-blockbuster Covid products.  Pfizer also…

Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion

[ad_1] Test tubes are seen in front of a displayed AbbVie logo in this illustration taken on May 21, 2021. Dado Ruvic | Reuters Biotech stocks rose Thursday as AbbVie…

Microsoft’s AI boost helped cloud business outpace rivals Amazon and Google in latest quarter

[ad_1] In the high-stakes cloud-computing battle, Microsoft is outpacing its top rivals. Third-quarter results are in for most mega-cap tech companies after a big week for tech earnings. On the…

Merck results beat expectations on strong Keytruda sales, surprise Covid drug growth

[ad_1] Merck headquarters in Rahway, New Jersey, on Tuesday, April 18, 2023. Christopher Occhicone | Bloomberg | Getty Images Merck on Thursday reported third-quarter revenue and adjusted earnings that topped…

Drugmakers opt in to Medicare drug price negotiations – here’s what happens next

[ad_1] A pharmacist holds a bottle of the drug Eliquis, made by Pfizer Pharmaceuticals, at a pharmacy in Provo, Utah, January 9, 2020. George Frey | Reuters All drugmakers of…